EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Modern psychopharmacology: systemic integration of molecular modeling, omics technologies, translational experimental models, and evidence-based clinical studies

Anastasia V. Voluiskaia, Tatiana S. Yaroslavtseva, Dmitry Yu. Ivkin, Ilya M. Sukhanov, Natalia V. Petukhova, Edwin E. Zvartau, Alexander O. Kibitov, Evgeny M. Krupitsky

Psychopharmacology and Addiction Biology · 08.09.2026 · 17 (2) · 71-80

DOI: 10.17816/phbn713547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychopharmacology and Addiction Biology, online erschienen am 08.09.2026. Verfasst von Anastasia V. Voluiskaia und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article summarizes the materials of three symposia on psychopharmacology held within the framework of the XIII All-Russian Conference with International Participation “Current Issues in Preclinical and Clinical Research of Medicinal Products and Clinical Trials of Medical Devices” (St. Petersburg, April 23–24, 2026). The development of modern psychopharmacology requires the implementation of personalized approaches, the application of molecular modeling and computational biology methods, and the integration of pharmacogenetic, pharmacoepigenomic, and multi-omics data into drug development and efficacy assessment processes. The priority areas for the development of modern psychopharmacology are: 1) implementation of integrated in silico pipelines at all stages of drug development; 2) active application of molecular modeling approaches for the creation of innovative drugs and targeted delivery systems; 3) development of standardized translational models ensuring high reproducibility and predictive value of experimental results at the preclinical research stage; and 4) integration of pharmacogenomic, pharmacoepigenomic, and multi-omics methods and assessments into the design of clinical studies. For the development of modern psychopharmacology, it is primarily necessary to: 1) improve the regulatory and methodological framework governing the use of modern digital and computational technologies, including artificial intelligence, in the development of medicinal products and medical devices; 2) resolve issues of standardization and validation of in silico modeling data, as well as introduce pharmacogenetic approaches into the clinical practice of psychiatry and addiction medicine; 3) develop a system of training specialists at the intersection of medicine, biology, bioinformatics, cheminformatics, and information technologies; and 4) create multidisciplinary research consortia. Thus, the further development of psychopharmacology is impossible without close systemic integration of fundamental research using omics technologies, computational technologies, translational models, and high-quality clinical studies. The implementation of such integrative projects will contribute to improving the efficiency of developing innovative drugs and to the advancement of personalized psychiatry and addiction medicine.

Zitieren

APA

Voluiskaia, A. V., Yaroslavtseva, T. S., Ivkin, D. Y., Sukhanov, I. M., Petukhova, N. V., Zvartau, E. E., Kibitov, A. O., & Krupitsky, E. M. (2026). Modern psychopharmacology: systemic integration of molecular modeling, omics technologies, translational experimental models, and evidence-based clinical studies. Psychopharmacology and Addiction Biology, 17(2), 71-80. https://doi.org/10.17816/phbn713547

Vancouver

Voluiskaia AV, Yaroslavtseva TS, Ivkin DY, Sukhanov IM, Petukhova NV, Zvartau EE, et al. Modern psychopharmacology: systemic integration of molecular modeling, omics technologies, translational experimental models, and evidence-based clinical studies. Psychopharmacology and Addiction Biology. 2026;17(2):71-80. doi:10.17816/phbn713547

BibTeX
@article{Voluiskaia2026,
  author = {Voluiskaia, Anastasia V. and Yaroslavtseva, Tatiana S. and Ivkin, Dmitry Yu. and Sukhanov, Ilya M. and Petukhova, Natalia V. and Zvartau, Edwin E. and Kibitov, Alexander O. and Krupitsky, Evgeny M.},
  title = {Modern psychopharmacology: systemic integration of molecular modeling, omics technologies, translational experimental models, and evidence-based clinical studies},
  journal = {Psychopharmacology and Addiction Biology},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {71--80},
  doi = {10.17816/phbn713547}
}
Kostenlos starten →